(Taken from the Application) This is an application for renewal of a longstanding program for predoctoral training in Pharmacological Sciences. Twelve training slots are requested to support students in their first two-years. The program seeks to meet the need for well-trained scientists who can maintain rapid progress in applying advances in biology to medicine. With the revolution in pharmacology over the last twenty years, rigorous training in molecular biology, genetics, biochemistry, structural biology, and cell biology as well as pharmacology forms the foundation of the program. These many disciplines are reflected in the research activities and classes offered to the students. The training program is conducted under the aegis of the Biological and Biomedical Sciences (BBS) graduate program at Harvard Medical School, which is comprised of four departments and affiliated faculty. The central department for this program is Biological Chemistry and Molecular Pharmacology with additional faculty from other Harvard departments. The various departments and the training grant faculty members are highly interactive. The research activities of the training grant faculty spans a broad spectrum of molecular pharmacology research with particular strengths in receptors, signal transduction, protein biochemistry and structure, molecular biology, and drug mechanisms and design. Students in the program take core courses covering basic sciences including pharmacology, and an advanced pharmacology course. Other courses offered stress reading papers and critical thinking and human biology. Full time thesis research follows course work, laboratory rotations, and qualifying examinations. Students have access to multiple other training activities including journal clubs, seminars, and data presentation. This training plan should ensure the strengthening or a program that has graduated many outstanding students who today play leadership roles in pharmacological sciences.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM007306-27
Application #
6498636
Study Section
National Institute of General Medical Sciences Initial Review Group (BRT)
Program Officer
Preusch, Peter C
Project Start
1975-07-01
Project End
2006-06-30
Budget Start
2002-07-01
Budget End
2003-06-30
Support Year
27
Fiscal Year
2002
Total Cost
$320,108
Indirect Cost
Name
Harvard University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Amin, Palak; Florez, Marcus; Najafov, Ayaz et al. (2018) Regulation of a distinct activated RIPK1 intermediate bridging complex I and complex II in TNF?-mediated apoptosis. Proc Natl Acad Sci U S A 115:E5944-E5953
Brown, Adam S; Kong, Sek Won; Kohane, Isaac S et al. (2016) ksRepo: a generalized platform for computational drug repositioning. BMC Bioinformatics 17:78
German, Natalie J; Yoon, Haejin; Yusuf, Rushdia Z et al. (2016) PHD3 Loss in Cancer Enables Metabolic Reliance on Fatty Acid Oxidation via Deactivation of ACC2. Mol Cell 63:1006-20
Levine, Zebulon G; Walker, Suzanne (2016) The Biochemistry of O-GlcNAc Transferase: Which Functions Make It Essential in Mammalian Cells? Annu Rev Biochem 85:631-57
Brown, Adam S; Patel, Chirag J (2015) aRrayLasso: a network-based approach to microarray interconversion. Bioinformatics 31:3859-61
Chiasson-MacKenzie, Christine; Morris, Zachary S; Baca, Quentin et al. (2015) NF2/Merlin mediates contact-dependent inhibition of EGFR mobility and internalization via cortical actomyosin. J Cell Biol 211:391-405
Barclay, Lauren A; Wales, Thomas E; Garner, Thomas P et al. (2015) Inhibition of Pro-apoptotic BAX by a noncanonical interaction mechanism. Mol Cell 57:873-886
Malone, Clare F; Fromm, Jody A; Maertens, Ophélia et al. (2014) Defining key signaling nodes and therapeutic biomarkers in NF1-mutant cancers. Cancer Discov 4:1062-73
Herman, Jonathan D; Rice, Daniel P; Ribacke, Ulf et al. (2014) A genomic and evolutionary approach reveals non-genetic drug resistance in malaria. Genome Biol 15:511
Dickson, John R; Kruse, Carla; Montagna, Daniel R et al. (2013) Alternative polyadenylation and miR-34 family members regulate tau expression. J Neurochem 127:739-49

Showing the most recent 10 out of 35 publications